Li‐Tzong Chen
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Co-authors
- Yan‐Shen Shan (60 shared papers)Ann‐Lii Cheng (33 shared papers)Jeffrey S. Chang (15 shared papers)Jang‐Yang Chang (25 shared papers)Yoon‐Koo Kang (15 shared papers)Kun‐Huei Yeh (20 shared papers)Wen‐Chun Hung (16 shared papers)Nai‐Jung Chiang (44 shared papers)
- Journals
- Journal of Clinical Oncology (48 papers)Oncotarget (9 papers)Scientific Reports (9 papers)Cancers (7 papers)Clinical Cancer Research (6 papers)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Li‐Tzong Chen
287 papers receiving 7.3k citations
Li‐Tzong Chen's Hit Papers
Peers
Comparison fields: 5 of 129
- Hepatology 1.0k
- Gastroenterology 503
- Oncology 2.0k
- Cancer Research 938
- Pathology and Forensic Medicine 835
Countries citing papers authored by Li‐Tzong Chen
This map shows the geographic impact of Li‐Tzong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Tzong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Tzong Chen more than expected).
Fields of papers citing papers by Li‐Tzong Chen
This network shows the impact of papers produced by Li‐Tzong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Tzong Chen. The network helps show where Li‐Tzong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Li‐Tzong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 297 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib Hit paper breakdown → | 2014 | 450 |
| 2 | Management of gastric cancer in Asia: resource-stratified guidelines Hit paper breakdown → | 2013 | 385 |
| 3 | 2009 | 326 | |
| 4 | 2019 | 212 | |
| 5 | 2004 | 183 | |
| 6 | A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1. Hit paper breakdown → | 2022 | 164 |
| 7 | 2016 | 153 | |
| 8 | 2013 | 134 | |
| 9 | 2005 | 128 | |
| 10 | 2013 | 120 | |
| 11 | 2010 | 117 | |
| 12 | 2011 | 110 | |
| 13 | 2018 | 98 | |
| 14 | 2012 | 95 | |
| 15 | 2004 | 81 | |
| 16 | 2017 | 77 | |
| 17 | 2017 | 74 | |
| 18 | 2015 | 71 | |
| 19 | 2004 | 69 | |
| 20 | 2013 | 69 |
About Li‐Tzong Chen
Li‐Tzong Chen is a scholar working on Oncology, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 297 papers that have together received 7.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (65 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers), Gastric Cancer Management and Outcomes (31 papers), Gastrointestinal Tumor Research and Treatment (20 papers), Colorectal Cancer Treatments and Studies (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Neuroendocrine Tumor Research Advances (19 papers) and Lymphoma Diagnosis and Treatment (17 papers). The work is most often cited by research in Hepatology (1.0k citations), Gastroenterology (503 citations), Oncology (2.0k citations), Cancer Research (938 citations) and Pathology and Forensic Medicine (835 citations). Li‐Tzong Chen has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Yan‐Shen Shan, Ann‐Lii Cheng, Jeffrey S. Chang, Jang‐Yang Chang, Yoon‐Koo Kang, Kun‐Huei Yeh, Wen‐Chun Hung, Nai‐Jung Chiang, Chiun Hsu and Chien‐Feng Li. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Scientific Reports, Cancers and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.